All In Biotech

Free tool

FAERS Monitor: Edluar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021997 or its brand name (Edluar, Zolpidem Tartrate). Reports on generic versions are filed under their own applications.

Reports

24,224

Serious

18,178

75% of reports

Hospitalization

9,226

Death reported

3,298

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,466
  • nausea1,248
  • fatigue1,173
  • insomnia997
  • diarrhoea941
  • fall935
  • headache920
  • completed suicide894
  • pain812
  • vomiting808
  • dizziness801
  • somnolence778
  • drug abuse772
  • dyspnoea771
  • toxicity to various agents765

Reports by year received

View as table
YearReports
2004528
2005572
2006578
2007726
2008618
2009604
2010600
2011660
2012875
2013603
2014609
20151,083
20161,591
20171,309
20181,686
20191,476
20201,330
20211,245
20221,571
20231,543
20241,688
20251,541
20261,188

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,935 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
completed suicideSignal8949.48.86,661
drug abuseSignal7728.17.64,786
toxicity to various agentsSignal7654.03.71,690
somnolenceSignal7783.43.11,298
insomniaSignal9973.33.11,573
fallSignal9352.42.3806
vomiting8081.51.4134
dizziness8011.41.391
nausea1,2481.41.3129
fatigue1,1731.31.288
headache9201.31.256
diarrhoea9411.31.254
dyspnoea7711.21.122
pain8121.11.116
drug ineffective1,4661.00.92

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.